My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, PubMatic, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CHTR CTO KLC PUBM
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
HALA raises $157m in one of the Middle East’s largest fintech Series B rounds, led by TPG and Sanabil Investments
From Hala
Via GlobeNewswire
Celestica to Hold Q3 2025 Financial Results Conference Call and 2025 Investor and Analyst Day
From Celestica International LP
Via GlobeNewswire
Tickers CLS TSX:CLS
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ALT SLQT
NOVO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers NVO
LINEAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lineage, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers LINE
Mobix Labs Files Form 425 With the SEC, Announces Intention to Launch Hostile Tender Offer for Peraso; Criticizes Recent Dilutive Financing and Efforts to Restrict Shareholder Communications
From Mobix Labs, Inc.
Via GlobeNewswire
Tickers MOBX PRSO
Forterra and Volvo Defense Demonstrate Integrated Autonomous Mission Systems in Vehicle Platforms
From Forterra
Via GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (NASDAQ: LNTH)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LNTH
OTC Markets Group Expands Data Availability via ICE Consolidated Feed, Unlocking Greater Global Access to Overnight Trading
From OTC Markets
Via GlobeNewswire
Tickers ICE OTCM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Sable Offshore Corp. (NYSE: SOC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SOC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Flywire Corporation (NASDAQ: FLYW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYW
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers NVO
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against KinderCare Learning Companies, Inc. (NYSE: KLC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers KLC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Dow Inc. (NYSE: DOW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers DOW
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
From Monte Rosa Therapeutics, Inc.
Via GlobeNewswire
Tickers GLUE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against C3.ai, Inc. (NYSE: AI)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers AI
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
From Can-Fite BioPharma Ltd.
Via GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Fly-E Group, Inc. (NASDAQ: FLYE)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Charter Communications, Inc. (NASDAQ: CHTR)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers CHTR
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against SelectQuote, Inc. (NYSE: SLQT)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SLQT
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lockheed Martin Corporation (NYSE: LMT)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LMT
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (NASDAQ: REPL)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers REPL
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Snap Inc. (NYSE: SNAP)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SNAP
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lineage, Inc. (NASDAQ: LINE)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LINE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Tronox Holdings PLC (NYSE: TROX)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers TROX
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers RXST
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (NASDAQ: LFMD)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LFMD
Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
From Perspective Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.